Tag Archives: Nexium

Recently, the company AstraZeneca has informed the approval of new indications for the Nexium drug – prevention of rebleeding from peptic ulcers after endoscopic hemostasis (for intravenous form of the drug) and long acid inhibits therapy in patients who had … Continue reading →